The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
21
No.
25
June 23, 1995
- Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion
- In Brief: Mansfield To Head NCI Radiation Research; Cowan Is Acting Chief, Medicine Branch
- Univ. of Chicago Hospital Apologizes For Overdose Death
- DCT Advisors Approve Recompetition Of Drug Discovery Groups
- Gastrointestinal SPORE To Be Recompeted
- Letter: ORI And Plotkin Should Release Report
- Small Business Technology Transfer Program Solicitation
TCL
Vol.
21
No.
26
June 30, 1995
TCL
Vol.
21
No.
27
July 07, 1995
- Review Of NCI Intramural Program Offers Over 60 Recommendations For Change
- In Brief: Budget Resolution Calls For 1% Cut In NIH, Then Six Years At 3% Below Current Budget
- “With resources now constrained, the ability of NCI to be responsive to its constituencies has been compromised.”
- “Too much [of NCI’s] planning is reactive rather than proactive. As a consequence, vision suffers.”
- “The Working Group urges NCI to reconsider its current budget to determine whether the 25 percent devoted to the IRP is appropriate.”
- Letter In Response To Hadley; RFA Available
TCL
Vol.
21
No.
28
July 14, 1995
- Working Group: Restructure NCI, Improve Review Process, Encourage Independence
- In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb
- “Significant changes should be made to reduce redundancy, streamline operations, promote collaboration, and optimize productivity.”
- “Perhaps the most troubling finding was a broad dissatisfaction with the general ethos within the intramural community.”
TCL
Vol.
21
No.
29
July 21, 1995
- NCI Clinical Research Too Similar To Work By Extramural Community, Report Finds
- House Panel Recommends $642 Million Increase For NIH; $31 Million Increase For NCI
- “Clinical research of all kinds in the IRP lacks a rigorous, centralized process for peer review.”
- “A significant reduction in the NCI IRP AIDS program may be in order, and released funds should … increase the pool available to extramural research.”
- “NCI activities at Frederick are not well integrated…. It would be wise to reorganize and consolidate.”
- In Brief: Grace Powers Monaco Receives Lloyd Bentsen Award
TCL
Vol.
21
No.
30
July 28, 1995
- White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director
- In Brief: House Committee Approves Funding Boost For NIH; Michigan Centers Receive $15M Gift
- FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing
- ACS Funds Pilot Study Of Mammography Trial
- Letter: The Lesson From Dana-Farber
TCL
Vol.
21
No.
31
August 04, 1995
- House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments
- In Brief: ASCO Congratulates Klausner; UCLA Names Gasson Head Of Jonsson Center
- Scientific Opportunity Should Guide Fund Allocation, House Says
- House: NCI Should Coordinate National Cancer Program
- ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer
- ORI Finds Misconduct By CIT Professor
- SAIC Frederick Offers Use Of Drug Facility
TCL
Vol.
21
No.
32
August 11, 1995
- Klausner Unveils New NCI Structure, Aims To Change Institute’s “Ethos”
- In Brief: ACS Awards Professorship To Bernstein; HCFA Clears Dana-Farber For Medicare
- Alan Rabson Named NCI Deputy Director
- Seven Divisions Proposed, Separating Intramural, Extramural Programs
- Staff Advisory Boards To Be Formed; Three BSCs Proposed
- NCI Exceeded Mandate In Study Of Legislators, Rep. Porter Says
- Managed Care Limits Access To Trials, Cancer Panel Says